Role for nephritogenic T cells in lupus glomerulonephritis: Progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 8258-8265

  Bagavant, Harini ^a   Deshmukh, Umesh S ^a   Wang, Hongyang ^a   Ly, Timothy ^a   Shu, Man Fu ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; FATALITY; FEMALE; GENDER; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN FAMILY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

EID: 33751554877     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.8258     Document Type: Article

References (40)

1. Lahita, R. G. 1999. The clinical presentation of systemic lupus erythematosus. In Systemic Lupus Erythematosus. R. G. Lahita, ed. Academic Press, San Diego, pp. 325-336.
2. Wofsy, D. 1993. Treatment of murine lupus with anti-CD4 monoclonal antibodies. Immunol. Ser. 59: 221-236.
3. Wofsy, D., J. A. Ledbetter, P. L. Hendler, and W. E. Seaman. 1985. Treatment of murine lupus with monoclonal anti-T cell antibody. J. Immunol. 134: 852-857.
4. + T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus. J. Immunol. 167: 2354-2360.
5. Tipping, P. G., and S. R. Holdsworth. 2003. T cells in glomerulonephritis. Springer Semin. Immunopathol. 24: 377-393.
6. Rudofsky, U. H., B. D. Evans, S. L. Balaban, V. D. Mottironi, and A. E. Gabrielsen. 1993. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice: origins and initial characterization. Lab. Invest. 68: 419-426.
7. Waters, S. T., S. M. Fu, F. Gaskin, U. S. Deshmukh, S. S. Sung, C. C. Kannapell, K. S. Tung, S. B. McEwen, and M. McDuffie. 2001. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin. Immunol. 100: 372-383.
8. Waters, S. T., M. McDuffie, H. Bagavant, U. S. Deshmukh, F. Gaskin, C. Jiang, K. S. Tung, and S. M. Fu. 2004. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J. Exp. Med. 199: 255-264.
9. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177: 1367-1381.
10. Bernstein, K. A., R. D. Valerio, and J. B. Lefkowith. 1995. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J. Immunol. 154: 2424-2433.
11. Zhao, Z., E. Weinstein, M. Tuzova, A. Davidson, P. Mundel, P. Marambio, and C. Putterman. 2005. Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential. Arthritis Rheum. 52: 522-530.
12. Bagavant, H., C. Thompson, K. Ohno, Y. Setiady, and K. S. Tung. 2002. Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease. Int. Immunol. 14: 1397-1406.
13. Clynes, R., C. Dumitru, and J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279: 1052-1054.
14. Singh, R. R., V. Saxena, S. Zang, L. Li, F. D. Finkelman, D. P. Witte, and C. O. Jacob. 2003. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J. Immunol. 170: 4818-4825.
15. Alexopoulos, E., D. Seron, R. B. Hartley, and J. S. Cameron. 1990. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int. 37: 100-109.
16. + T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J. Immunol. 175: 944-950.
17. Pollack, P., and C. Pirani. 1969. Renal histologic findings in systemic lupus erythematosus. Mayo Clin. Proc. 44: 630-644.
18. Paulsson, G., X. Zhou, E. Tornquist, and G. K. Hansson. 2000. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20: 10-17.
19. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zoller, and P. Kourilsky. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 90: 4319-4323.
20. Bao, L., J. Zhou, V. M. Holers, and R. J. Quigg. 2003. Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. J. Am. Soc. Nephrol. 14: 2516-2525.
21. Bao, L., M. Haas, S. A. Boackle, D. M. Kraus, P. N. Cunningham, P. Park, J. J. Alexander, R. K. Anderson, K. Culhane, V. M. Holers, and R. J. Quigg. 2002. Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J. Immunol. 168: 3601-3607.
22. Perez De Lema, G., H. Maier, E. Nieto, V. Vielhauer, B. Luckow, F. Mampaso, and D. Schlondorff. 2001. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J. Am. Soc. Nephrol. 12: 1369-1382.
23. De Albuquerque, D. A., V. Saxena, D. E. Adams, G. P. Boivin, H. I. Brunner, D. P. Witte, and R. R. Singh. 2004. An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis. Kidney Int. 65: 846-859.
24. Patole, P. S., H. J. Grone, S. Segerer, R. Ciubar, E. Belemezova, A. Henger, M. Kretzler, D. Schlondorff, and H. J. Anders. 2005. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J. Am. Soc. Nephrol. 16: 1326-1338.
25. Anders, H. J., V. Vielhauer, V. Eis, Y. Linde, M. Kretzler, D. L. Perez, F. Strutz, S. Bauer, M. Rutz, H. Wagner, et al. 2004. Activation of Toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 18: 534-536.
26. 1 mice by a mechanism downstream of renal immune complex deposition. J. Immunol. 171: 489-497.
27. Serafini, B., S. Columba-Cabezas, F. Di Rosa, and F. Aloisi. 2000. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157: 1991-2002.
28. Suter, T., U. Malipiero, L. Otten, B. Ludewig, A. Muelethaler-Mottet, B. Mach, W. Reith, and A. Fontana. 2000. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis. Eur. J. Immunol. 30: 794-802.
29. Ponomarev, E. D., L. P. Shriver, K. Maresz, and B. N. Dittel. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci. Res. 81: 374-389.
30. McMahon, E. J., S. L. Bailey, C. V. Castenada, H. Waldner, and S. D. Miller. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11: 335-339.
31. Chan, O. T., M. P. Madaio, and M. J. Shlomchik. 1999. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J. Immunol. 163: 3592-3596.
32. Chan, O. T., L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189: 1639-1648.
33. Massengill, S. F., M. M. Goodenow, and J. W. Sleasman. 1998. SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells. Am. J. Kidney Dis. 31: 418-426.
34. Bloom, R. D., T. O'Connor, B. Cizman, R. Kalluri, A. Naji, and M. P. Madaio. 2002. Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice. Int. Immunol. 14: 867-871.
35. + T cells recognizing specific antigen deposited in glomeruli cause glomerulonephritis-like kidney injury. Clin. Immunol. 104: 161-173.
36. Lang, T. J., P. Nguyen, J. C. Papadimitriou, and C. S. Via. 2003. Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J. Immunol. 171: 5795-5801.
37. Xie, C., X. J. Zhou, X. Liu, and C. Mohan. 2003. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum. 48: 1080-1092.
38. Xie, C., R. Sharma, H. Wang, X. J. Zhou, and C. Mohan. 2004. Strain distribution pattern of susceptibility to immune-mediated nephritis. J. Immunol. 172: 5047-5055.
39. Jelinsky, S. A., H. A. Harris, E. L. Brown, K. Flanagan, X. Zhang, C. Tunkey, K. Lai, M. V. Lane, D. K. Simcoe, and M. J. Evans. 2003. Global transcription profiling of estrogen activity: estrogen receptor a regulates gene expression in the kidney. Endocrinology 144: 701-710.
40. Shim, G. J., L. L. Kis, M. Warner, and J. A. Gustafsson. 2004. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor α gene. Proc. Natl. Acad. Sci. USA 101: 1720-1724.